SciELO - Scientific Electronic Library Online

 
vol.82 issue4Successful endovascular treatment of nutcracker's syndrome with self-expanding stentIs salt sensitive hypertension an inflammatory disease?: Role of lymphocytes and macrophages author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Archivos de cardiología de México

On-line version ISSN 1665-1731Print version ISSN 1405-9940

Abstract

GRIP, Laura T.  and  GIUGLIANO, Robert P.. Importance of dose selection in novel oral anticoagulants for atrial fibrillation. Arch. Cardiol. Méx. [online]. 2012, vol.82, n.4, pp.308-311. ISSN 1665-1731.  https://doi.org/10.1016/j.acmx.2012.10.001.

There are several excellent alternatives to warfarin on the horizon for atrial fibrillation. Results from the trials, as well as pharmacokinetic data from the edoxaban studies, suggest that dose selection, based on pharmacokinetic and pharmacodynamic properties, is a critical component in the development of novel anticoagulants. Greater flexibility in dosing with edoxaban and the opportunity for dose adjustment throughout the ENGAGE AF-TIMI 48 trial may be advantageous in the competitive field of novel oral anticoagulants.

Keywords : Atrial fibrillation; Oral anticoagulants; Warfarin; Intracranial bleeding; USA.

        · abstract in Spanish     · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License